Ultragenyx Pharmaceutical shares owned by Vanguard Group
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $415M | 8.7M | 47.82 |
| 2023-09-30 | $258M | 7.2M | 35.65 |
| 2023-06-30 | $324M | 7.0M | 46.13 |
| 2023-03-31 | $271M | 6.8M | 40.10 |
| 2022-12-31 | $295M | 6.4M | 46.33 |
| 2022-06-30 | $366M | 6.1M | 59.66 |
| 2022-03-31 | $433M | 6.0M | 72.62 |
| 2021-09-30 | $530M | 5.9M | 90.19 |
| 2021-06-30 | $540M | 5.7M | 95.35 |
| 2021-03-31 | $671M | 5.9M | 113.86 |
| 2020-12-31 | $782M | 5.7M | 138.43 |
| 2020-09-30 | $440M | 5.4M | 82.19 |
| 2020-06-30 | $402M | 5.1M | 78.22 |
| 2020-03-31 | $221M | 5.0M | 44.43 |
| 2019-12-31 | $207M | 4.9M | 42.71 |
| 2019-09-30 | $217M | 5.1M | 42.82 |
| 2019-03-31 | $339M | 4.9M | 69.36 |
| 2018-12-31 | $181M | 4.2M | 43.52 |
| 2018-09-30 | $309M | 4.1M | 76.34 |
| 2018-06-30 | $313M | 4.1M | 76.87 |
| 2018-03-31 | $201M | 3.9M | 50.99 |
| 2017-12-31 | $147M | 3.2M | 46.38 |
| 2017-09-30 | $167M | 3.1M | 53.25 |
| 2017-06-30 | $194M | 3.1M | 62.11 |
| 2017-03-31 | $203M | 3.0M | 67.78 |
| 2016-12-31 | $199M | 2.8M | 70.39 |
| 2016-09-30 | $189M | 2.7M | 70.93 |
| 2016-06-30 | $127M | 2.6M | 48.91 |
| 2015-12-31 | $268M | 2.4M | 112.00 |
| 2015-09-30 | $203M | 2.1M | 96.00 |
| 2015-06-30 | $178M | 1.7M | 102.38 |
| 2015-03-31 | $99M | 1.6M | 62.09 |
| 2014-12-31 | $57M | 1.3M | 43.86 |
| 2014-09-30 | $62M | 1.1M | 56.60 |
| 2014-06-30 | $12M | 273k | 44.93 |
| 2014-03-31 | $11M | 214k | 48.94 |